Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Jiangsu Alphamab Biopharmaceuticals Co., Ltd

Clinical trials sponsored by Jiangsu Alphamab Biopharmaceuticals Co., Ltd, explained in plain language.

Trials to join now! 5 Not yet recruiting 6 Not yet finished but already full! 1 Completed 1 Terminated 1

New drug combo JSKN033 tested for Hard-to-Treat cancers

Disease control Terminated

This early-phase trial tested a new drug called JSKN033 in 11 people with advanced or spreading solid tumors that have a protein called HER2. The drug is a combination of two medicines given as a shot under the skin. The study aimed to check safety, side effects, and the right do…

Phase: PHASE1, PHASE2 • Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd • Aim: Disease control

Last updated Jun 26, 2026 16:37 UTC